[1] |
Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis[J]. Lancet, 2021, 397(10281):1301⁃1315. doi: 10.1016/S0140⁃6736(20)32549⁃6.
|
[2] |
Streicher F, Jouvenet N. Stimulation of innate immunity by host and viral RNAs[J]. Trends Immunol, 2019,40(12):1134⁃1148. doi: 10.1016/j.it.2019.10.009.
|
[3] |
Handfield C, Kwock J, MacLeod AS. Innate antiviral immunity in the skin[J]. Trends Immunol, 2018,39(4):328⁃340. doi: 10. 1016/j.it.2018.02.003.
|
[4] |
Strumillo ST, Kartavykh D, de Carvalho FF Jr, et al. Host⁃virus interaction and viral evasion[J]. Cell Biol Int, 2021,45(6):1124⁃1147. doi: 10.1002/cbin.11565.
|
[5] |
Yiu Z, Parisi R, Lunt M, et al. Risk of hospitalization and death due to infection in people with psoriasis: a population⁃based cohort study using the Clinical Practice Research Datalink[J]. Br J Dermatol, 2021,184(1):78⁃86. doi: 10.1111/bjd.19052.
|
[6] |
Yoneda K, Matsuoka⁃Shirahige Y, Demitsu T, et al. Pustular psoriasis precipitated by cytomegalovirus infection[J]. Br J Dermatol, 2012,167(5):1186⁃1189. doi: 10.1111/j.1365⁃2133. 2012.11044.x.
|
[7] |
Loh E, Fung MA, Maverakis E. Acute guttate psoriasis in a 15⁃year⁃old girl with Epstein⁃Barr virus infection[J]. Arch Dermatol, 2012,148(5):658⁃659. doi: 10.1001/archdermatol.2011. 3517.
|
[8] |
Jiyad Z, Moriarty B, Creamer D, et al. Generalized pustular psoriasis associated with Epstein⁃Barr virus[J]. Clin Exp Dermatol, 2015,40(2):146⁃148. doi: 10.1111/ced.12493.
|
[9] |
Chen ML, Kao WM, Huang JY, et al. Human papillomavirus infection associated with increased risk of new⁃onset psoriasis: a nationwide population⁃based cohort study[J]. Int J Epidemiol, 2020,49(3):786⁃797. doi: 10.1093/ije/dyaa027.
|
[10] |
李远宏, 陈光, 张理涛, 等. 银屑病患者皮损及鳞屑中人乳头瘤病毒的检测[J]. 中华皮肤科杂志, 2008,41(10):695⁃696. doi: 10.3321/j.issn:0412⁃4030.2008.10.020.
|
[11] |
王官清, 张理涛, 徐宏慧, 等. 寻常型银屑病与单纯疱疹病毒1型相关性的研究[J]. 中华皮肤科杂志, 2002,35(2):102⁃104. doi: 10.3760/j.issn:0412⁃4030.2002.02.007.
|
[12] |
Queirós N, Torres T. HIV⁃associated psoriasis[J]. Actas Dermosifiliogr (Engl Ed), 2018,109(4):303⁃311. doi: 10.1016/j.ad.2017.09.014.
|
[13] |
Li YY, Dong RJ, Cao LJ, et al. Case of coincident severe acne and psoriasis in AIDS patient successfully treated with antiretroviral therapy[J]. J Dermatol, 2019,46(5):431⁃435. doi: 10.1111/1346⁃8138.14823.
|
[14] |
Bowles AA, Smirnov B. Erythrodermic psoriasis and HIV infection[J]. N Engl J Med, 2019,380(1):80. doi: 10.1056/NEJMicm1810005.
|
[15] |
Kuwatsuka S, Koike Y, Asai M, et al. Numerous plasmacytoid dendritic cell infiltration in HIV⁃associated psoriasis relieved only with antiretroviral therapy[J]. J Dermatol, 2018,45(9):1126⁃1129. doi: 10.1111/1346⁃8138.14525.
|
[16] |
Seetharam KA, Sridevi K. Chikungunya infection: a new trigger for psoriasis[J]. J Dermatol, 2011,38(10):1033⁃1034. doi: 10. 1111/j.1346⁃8138.2011.01200.x.
|
[17] |
Sbidian E, Madrange M, Viguier M, et al. Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds[J]. Br J Dermatol, 2019,181(6):1304⁃1306. doi: 10.1111/bjd.18203.
|
[18] |
Shahidi Dadras M, Diab R, Ahadi M, et al. Generalized pustular psoriasis following COVID⁃19[J]. Dermatol Ther, 2021,34(1):e14595. doi: 10.1111/dth.14595.
|
[19] |
Novelli L, Motta F, Ceribelli A, et al. A case of psoriatic arthritis triggered by SARS⁃CoV⁃2 infection[J]. Rheumatology (Oxford), 2021,60(1):e21⁃e23. doi: 10.1093/rheumatology/keaa691.
|
[20] |
Gananandan K, Sacks B, Ewing I. Guttate psoriasis secondary to COVID⁃19[J]. BMJ Case Rep, 2020,13(8):e237367. doi: 10.1136/bcr⁃2020⁃237367.
|
[21] |
Ferreira CR, Crow YJ, Gahl WA, et al. DDX58 and classic Singleton⁃Merten syndrome[J]. J Clin Immunol, 2019,39(1):75⁃80. doi: 10.1007/s10875⁃018⁃0572⁃1.
|
[22] |
Prasov L, Bohnsack BL, El Husny AS, et al. DDX58(RIG⁃I)⁃related disease is associated with tissue⁃specific interferon pathway activation[J]. J Med Genet, 2022,59(3):294⁃304. doi: 10.1136/jmedgenet⁃2020⁃107447.
|
[23] |
Abu Tayeh A, Funabiki M, Shimizu S, et al. Psoriasis⁃like skin disorder in transgenic mice expressing a RIG⁃I Singleton⁃Merten syndrome variant[J]. Int Immunol, 2021,33(4):211⁃224. doi: 10.1093/intimm/dxaa071.
|
[24] |
Yao Y, Richman L, Morehouse C, et al. Type I interferon: potential therapeutic target for psoriasis?[J]. PLoS One, 2008,3(7):e2737. doi: 10.1371/journal.pone.0002737.
|
[25] |
Wang X, Liu X, Liu N, et al. Prediction of crucial epigenetically⁃associated, differentially expressed genes by integrated bioinformatics analysis and the identification of S100A9 as a novel biomarker in psoriasis[J]. Int J Mol Med, 2020,45(1):93⁃102. doi: 10.3892/ijmm.2019.4392.
|
[26] |
Gao Y, Yao X, Zhai Y, et al. Single cell transcriptional zonation of human psoriasis skin identifies an alternative immunoregula⁃tory axis conducted by skin resident cells[J]. Cell Death Dis, 2021,12(5):450. doi: 10.1038/s41419⁃021⁃03724⁃6.
|
[27] |
Li Y, Song Y, Zhu L, et al. Interferon kappa is up⁃regulated in psoriasis and it up⁃regulates psoriasis⁃associated cytokines in vivo[J]. Clin Cosmet Investig Dermatol, 2019,12:865⁃873. doi: 10.2147/CCID.S218243.
|
[28] |
Sevimoglu T, Turanli B, Bereketoglu C, et al. Systems biomarkers in psoriasis: integrative evaluation of computational and experimental data at transcript and protein levels[J]. Gene, 2018,647:157⁃163. doi: 10.1016/j.gene.2018.01.033.
|
[29] |
Zhou Y, Wang P, Yan BX, et al. Quantitative proteomic profile of psoriatic epidermis identifies OAS2 as a novel biomarker for disease activity[J]. Front Immunol, 2020,11:1432. doi: 10. 3389/fimmu.2020.01432.
|
[30] |
Lande R, Gregorio J, Facchinetti V, et al. Plasmacytoid dendritic cells sense self⁃DNA coupled with antimicrobial peptide[J]. Nature, 2007,449(7162):564⁃569. doi: 10.1038/nature06116.
|
[31] |
Pahar B, Madonna S, Das A, et al. Immunomodulatory role of the antimicrobial LL⁃37 peptide in autoimmune diseases and viral infections[J]. Vaccines (Basel), 2020,8(3):517. doi: 10.3390/vaccines8030517.
|
[32] |
Ganguly D, Chamilos G, Lande R, et al. Self⁃RNA⁃antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8[J]. J Exp Med, 2009,206(9):1983⁃1994. doi: 10. 1084/jem.20090480.
|
[33] |
Zhang LJ, Sen GL, Ward NL, et al. Antimicrobial peptide LL37 and MAVS signaling drive interferon⁃β production by epidermal keratinocytes during skin injury[J]. Immunity, 2016,45(1):119⁃130. doi: 10.1016/j.immuni.2016.06.021.
|
[34] |
Lande R, Botti E, Jandus C, et al. The antimicrobial peptide LL37 is a T⁃cell autoantigen in psoriasis[J]. Nat Commun, 2014,5:5621. doi: 10.1038/ncomms6621.
|
[35] |
Zhang LJ. Type1 interferons potential initiating factors linking skin wounds with psoriasis pathogenesis[J]. Front Immunol, 2019,10:1440. doi: 10.3389/fimmu.2019.01440.
|
[36] |
Afshar M, Martinez AD, Gallo RL, et al. Induction and exacerbation of psoriasis with Interferon⁃alpha therapy for hepatitis C: a review and analysis of 36 cases[J]. J Eur Acad Dermatol Venereol, 2013,27(6):771⁃778. doi: 10.1111/j.1468⁃3083.2012.04582.x.
|
[37] |
Gui J, Gober M, Yang X, et al. Therapeutic elimination of the type 1 interferon receptor for treating psoriatic skin inflammation[J]. J Invest Dermatol, 2016,136(10):1990⁃2002. doi: 10.1016/j.jid.2016.06.608.
|
[38] |
Fu LX, Chen T, Guo ZP, et al. Enhanced serum interferon⁃lambda 1 interleukin⁃29 levels in patients with psoriasis vulgaris[J]. An Bras Dermatol, 2021,96(4):416⁃421. doi: 10.1016/j.abd. 2020.11.007.
|
[39] |
Wolk K, Witte K, Witte E, et al. IL⁃29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis[J]. Sci Transl Med, 2013,5(204):204ra129. doi: 10. 1126/scitranslmed.3006245.
|
[40] |
Zhu H, Lou F, Yin Q, et al. RIG⁃I antiviral signaling drives interleukin⁃23 production and psoriasis⁃like skin disease[J]. EMBO Mol Med, 2017,9(5):589⁃604. doi: 10.15252/emmm.2016 07027.
|
[41] |
Bijlmakers MJ, Kanneganti SK, Barker JN, et al. Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double⁃stranded RNA in disease pathogenesis[J]. Hum Mol Genet, 2011,20(16):3129⁃3137. doi: 10.1093/hmg/ddr215.
|
[42] |
Lima⁃Junior DS, Krishnamurthy SR, Bouladoux N, et al. Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota[J]. Cell, 2021,184(14):3794⁃3811.e19. doi: 10.1016/j.cell.2021.05.020.
|
[43] |
Ariza ME, Williams MV. A human endogenous retrovirus K dUTPase triggers a TH1, TH17 cytokine response: does it have a role in psoriasis?[J]. J Invest Dermatol, 2011,131(12):2419⁃2427. doi: 10.1038/jid.2011.217.
|